Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Evolving R&D Model Pressures Contract Services Market

The R&D model is in transition and creating new demands on contract services providers.
Jan 31, 2014

The R&D model is in transition and creating new demands on contract services providers.

Climate Change Drives New Opportunities in Outsourcing

Ongoing changes create new opportunities for CROs and CMOs.
Jan 2, 2014

Ongoing changes create new opportunities for CROs and CMOs.

R&D in Transition

The R&D model is in transition and creating new demands on contract services providers.
Jan 2, 2014

The R&D model is in transition and creating new demands on contract services providers.

Climate Change in Outsourcing

Ongoing changes create new opportunities for CROs and CMOs.
Dec 2, 2013

Ongoing changes create new opportunities for CROs and CMOs.

The Expense of Vision in Outsourcing

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.
Nov 6, 2013

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

The Expense of Vision in Outsourcing

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.
Oct 2, 2013

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

Outsourcing Partnerships for CMC Development

Are strategic partnerships in clinical research a model for CMC services?
Oct 1, 2013

Are strategic partnerships in clinical research a model for CMC services?

Outsourcing Partnerships for CMC Development

Are strategic partnerships in clinical research a model for CMC services?
Sep 2, 2013

Are strategic partnerships in clinical research a model for CMC services?

Stability Reigns in Contract Services

The PharmTech/PharmSource annual outsourcing survey results suggest that CDMOs may be getting complacent.
Aug 1, 2013

The PharmTech/PharmSource annual outsourcing survey results suggest that CDMOs may be getting complacent.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here